Kenvue Inc. has announced a leadership change and the initiation of a strategic review aimed at optimizing its brand portfolio and operating model. Kirk Perry, a Kenvue board member and former ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the ...

Kirk Perry has been named interim CEO, effective immediately, as the board conducts a search for Mongon's permanent successor ...

Kenvue shares (KVUE) are in focus Monday after the consumer health firm ousted its CEO, Thibaut Mongon, and announced a ...

Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...

All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director ...

Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.

Current Kenvue Director, Kirk Perry, is named Interim CEO, effective immediately. Kenvue Board of Directors appointed a new ...

American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...

Seeking Alpha's daily roundup of remarks and statements that could impact markets, sectors or individual stocks. Read more here.

Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a ...

Kenvue names interim CEO, begins strategic review to simplify operations and considers divesting smaller beauty brands amid ...